ROLE OF Y-CARBOXYGLUTAMIC ACID IN BLOOD COAGULATION
Project Number5R01HL020161-09
Contact PI/Project LeaderHISKEY, RICHARD G
Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
The calcium ion binding and phospholipid binding behavior of prothrombin
necessary for optimal rates of thrombin production in the blood coagulation
process depend on the presence of gamma-carboxyglutamic acid (Gla)
residues. This vitamin K-dependent amino acid is located at ten positions
within the first 33 residues of prothromibin and at similar positions in
the other vitamin K-dependent coagulation proteins factors VII, IX, X and
Protein C. A related gamma-carboxyglutamix-containing region also occurs
in bone proteins. We suggest that the 1-40 region of prothrombin,
containing the 18-23 cystine loop, is critical to the functional behavior
of prothrombin as well as related structures of the other vitamin
K-dependent coagulation factors and perhaps other proteins, such as the
bone protein, containing Gla and a similar cystine loop. We intend to
prepare segments of the 1-40 region by chemical synthesis; we will also
utilize the peptides representing the 1-39 and 12-44 sequences obtained
from prothrombin. We intend to establish; (a) the chemical structure of
the smallest unit of the amino terminal region of prothrombin that will
exhibit the metal ion-induced characteristics of the protein; (b) the role
of the cystine loop; (c) the nature of the ligand system in the Gla region
that is required for metal ion binding; and, (d) the minimum number and
location of Gla residues in the 1-33 sequence necessary for
prothrombin-phospholipid interaction. Experimental techniques that will be
employed to study the chemical and physical properties of these synthetic
and natural peptides include nuclear magnetic resonance, laser Raman and
Emu3+ luminescence spectroscopy; metal ion binding; interaction with
antibodies specific to the calcium ion-induced conformation; and peptide;
solvent and peptide:lipid partition experiments. A method for chemical
modification of Gla residues is also proposed.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
arginineblood coagulationblood coagulation testscalciumchemical bindingchemical structure functioncircular dichroismcoagulation factor IXcoagulation factor VIIcoagulation factor Xcongenital blood protein disordercystinefluorimetrygel filtration chromatographyhemophilia Bhuman subjectmalonatesmolecular pathologynuclear magnetic resonance spectroscopynutrition related tagphospholipidsprotein Cprothrombinradiotracervitamin K
No Sub Projects information available for 5R01HL020161-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HL020161-09
Patents
No Patents information available for 5R01HL020161-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HL020161-09
Clinical Studies
No Clinical Studies information available for 5R01HL020161-09
News and More
Related News Releases
No news release information available for 5R01HL020161-09
History
No Historical information available for 5R01HL020161-09
Similar Projects
No Similar Projects information available for 5R01HL020161-09